In order to dispel some comments heard in the clinical and research genetics communities, we have decided to issue the following statement:
"Cyrillic 2.1.3 and Cyrillic 3.0.400 remain on sale and are fully supported by our company.
We are engaged in a number of research projects in the UK, Europe and the USA that we hope will lead to the release of a successor or complementary element to the current product range sometime during 2003.
In the mean time, from our new UK headquarters in Reading and via our network of resellers, we will continue to sell and provide full support for the existing Cyrillic products.
We would like to take this opportunity to thank the Cyrillic community for their continuing support of CyrillicSoftware."
Please direct enquiries to AP Benson.